Ads
related to: kinase
Search results
Opinion | Ending Oncology's Toxic Relationship With High Chemotherapy Doses
MedPage Today· 4 days agoIn my practice, which focuses exclusively on treating patients with leukemias and related myeloid...
What's Going On With Reneo Pharmaceuticals Stock Today? - Reneo Pharmaceuticals (NASDAQ:RPHM)
Benzinga· 18 hours agoThe resulting company, expected to operate as OnKure Therapeutics, will focus on advancing OnKure’s...
Earnings call: Fulcrum Therapeutics partners with Sanofi on FSHD drug By Investing.com
Investing.com· 11 hours agoFulcrum (LON:FMETF) Therapeutics (ticker: NASDAQ:FULC) has entered into a significant collaboration...
Getting to know the enzymes behind cell communication—and tumor growth
Phys.org· 6 days agoIn a new study, Yale pharmacologist Benjamin Turk and his colleagues developed tools that can help researchers hone in on the roles of individual kinases and begin to uncover ...
Reneo Pharmaceuticals and OnKure Announce Proposed Merger - Reneo Pharmaceuticals (NASDAQ:RPHM)
Benzinga· 24 hours agoThe combined company will focus on advancing OnKure's pipeline candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), including its lead program ...
Improving the safety of iPS cell-derived pancreatic islets by eliminating unwanted cells
Medical Xpress· 21 hours agoThe study is published in the Proceedings of the National Academy of Sciences and was led by Junior Associate Professor Taro Toyoda (Department of Life Science Frontiers, CiRA) and included ...
FY2024 Earnings Estimate for Curis, Inc. Issued By Cantor Fitzgerald (NASDAQ:CRIS)
ETF DAILY NEWS· 1 day agoCuris, Inc. (NASDAQ:CRIS – Free Report) – Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for Curis in a research note issued on Wednesday, May 8th. Cantor Fitzgerald ...
Cambridge-NYC biotech gets $95M, prepares to enter clinic with blood cancer drug - Boston Business...
The Business Journals· 1 day agoA local biotech has not only raised $95 million, but announced it plans to bring its first drug into...
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
FOX21 Colorado Springs· 6 days agoKyowa Kirin Co., Ltd. (TSE: 4151) today announced that data from the pre-clinical pharmacokinetics & efficacy study comparing ocular tissue distribution after ocular instillation of tivozanib ...
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 2 days agoIts two most important markets are renal cell carcinoma (RCC, a type of kidney cancer) and...